Stocks · Health care · Pharmaceutical Preparations

Harmony Biosciences Holdings, Inc.

HRMY Clue Score72
United States Fiscal year ends December CIK 0001802665 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Sandip Kapadia
26 Jan 2026
Chief Financial Officer
Sold on a plan
3,746
$37.15
$139.17K
Sandip Kapadia
15 Jan 2026
Chief Financial Officer
Sold on a plan
20,961
$35.92
$752.83K
Sandip Kapadia
21 Nov 2025
Chief Financial Officer
Sold on a plan
3,427
$35.00
$119.95K
Sandip Kapadia
15 Aug 2025
Chief Financial Officer
Sold on a plan
21,573
$36.50
$787.38K
Sandip Kapadia
1 Apr 2025
Chief Financial Officer
Sold on a plan
740
$33.12
$24.51K
Sandip Kapadia
1 Apr 2025
Chief Financial Officer
Sold on a plan
6,247
$32.48
$202.88K
Sandip Kapadia
27 Jan 2025
Chief Financial Officer
Sold on a plan
1,775
$38.05
$67.55K
Jeffrey Dierks
27 Jan 2025
Chief Commercial Officer
Sold on a plan
1,629
$38.02
$61.94K

What was left out

Form 4 filings counted 182
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 74
Sales at will 104
Transactions with no price 0
Shares from compensation/vesting 28,755,795
Sales filed before the plan box existed 97
History held since 20 Aug 2020